These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10480736)

  • 1. Approaches and strategies for the treatment of influenza virus infections.
    Colacino JM; Staschke KA; Laver WG
    Antivir Chem Chemother; 1999 Jul; 10(4):155-85. PubMed ID: 10480736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The substances active against influenza virus. Possibilities and prospects of application].
    Kwiatek M; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-influenza drugs and neuraminidase inhibitors.
    Roberts NA
    Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction].
    Piotrovskiĭ LB; Kozeletskaia KN; Medvedeva NA; Dumpis MA; Pozniakova LI; Kiselev OI
    Vopr Virusol; 2001; 46(3):38-42. PubMed ID: 11450143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of siRNAs to prevent and treat influenza virus infection.
    Ge Q; Eisen HN; Chen J
    Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective of Use of Antiviral Peptides against Influenza Virus.
    Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
    Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
    Beyleveld G; White KM; Ayllon J; Shaw ML
    Antiviral Res; 2013 Oct; 100(1):120-32. PubMed ID: 23933115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ching-fang-pai-tu-san inhibits the release of influenza virus.
    Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
    J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Peptides as Anti-Influenza Agents.
    Agamennone M; Fantacuzzi M; Vivenzio G; Scala MC; Campiglia P; Superti F; Sala M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza chemotherapy: a review of the present state of art and of new drugs in development.
    Lüscher-Mattli M
    Arch Virol; 2000; 145(11):2233-48. PubMed ID: 11205114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.